Skip to main content
IYH logo

iShares U.S. Healthcare ETF (IYH) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$70.40 $0.00 (0.00%)
Vol: 615.7K|

Beta 0.57: the stock has moved about 43% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

iShares U.S. Healthcare ETF (IYH) trades at $70.40. The iShares U.S. Healthcare ETF (IYH) is an exchange-traded fund designed to track the performance of U.S. healthcare equities. Sector: Financials.

Price as of · Last analyzed: Jun 14, 2026
The iShares U.S. Healthcare ETF (IYH) is an exchange-traded fund designed to track the performance of U.S. healthcare equities. It provides investors with diversified exposure to the healthcare sector, encompassing pharmaceuticals, biotechnology, and healthcare services.

Analyst Coverage for IYH: IYH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the IYH film Every key number, told as a short cinematic story — just press play. ~2 min

iShares U.S. Healthcare ETF (IYH) Financial Services Profile

HeadquartersSan Francisco, US
IPO Year2000

iShares U.S. Healthcare ETF (IYH) offers diversified exposure to U.S. healthcare equities, including pharmaceuticals, biotechnology, and healthcare services, making it a strategic choice for investors seeking to capitalize on the growth of the healthcare sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 14, 2026

What Is the Investment Thesis for IYH?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

The iShares U.S. The ETF's focus on U.S. healthcare equities allows investors to capitalize on advancements in pharmaceuticals and biotechnology, which are expected to see increased funding and innovation. Furthermore, the aging population and rising healthcare expenditures are anticipated to drive demand for healthcare services, thereby benefiting the underlying companies in the ETF. With a market cap of $3.15 billion, IYH is well-positioned to leverage these growth catalysts. However, investors should remain cautious of ongoing regulatory scrutiny and potential policy changes that could impact profitability across the sector. Monitoring healthcare legislation will be critical for assessing the ETF's performance and the viability of its holdings.

Based on FMP financials and quantitative analysis

IYH Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $3.15 billion reflects significant investor interest and trust in the ETF.

  • Beta of 0.57 indicates lower volatility compared to the broader market, appealing to risk-averse investors.
  • Focus on U.S. healthcare equities provides exposure to a sector projected to grow at a CAGR of 7.9% through 2028.
  • No dividend yield, emphasizing a strategy focused on capital appreciation rather than income generation.
  • Diversified holdings across pharmaceuticals, biotechnology, and healthcare services mitigate sector-specific risks.

Who Are IYH's Competitors?

IYH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
EWC iShares MSCI Canada ETF $58.72 +0.75% $5.86B —
IFRA iShares U.S. Infrastructure ETF $56.19 +1.19% $4.25B —
BLK BlackRock, Inc. $1059.63 -0.44% $164B —
BX Blackstone Inc. $111.74 -0.45% $135B —
APOS Apollo Global Management, Inc. $25.59 -0.23% $74.8B —
BAM Brookfield Asset Management $44.85 +0.65% $71.6B —
AMP Ameriprise Financial, Inc. $490.91 -0.79% $44.1B —
ARES Ares Management Corporation $117.55 +0.84% $38.6B —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IYH's Key Strengths?

Strong market capitalization of $3.15 billion indicates investor confidence.

  • Diversified exposure to various healthcare sectors mitigates risks.
  • Managed by BlackRock, ensuring robust management and operational expertise.

What Are IYH's Weaknesses?

No dividend yield may deter income-focused investors.

  • Exposure to regulatory changes that could impact healthcare profitability.
  • Market volatility can affect ETF performance despite its defensive nature.

What Are the Key Risks for IYH?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

What Threats Does IYH Face?

  • Ongoing regulatory scrutiny and potential policy changes affecting the healthcare sector.
  • Economic downturns may impact investor sentiment toward equities.
  • Competition from other healthcare ETFs and investment vehicles.

What Are IYH's Competitive Advantages?

  • Managed by BlackRock, which has a strong reputation and extensive resources in asset management.
  • Diversified holdings across multiple healthcare sub-sectors reduce exposure to individual company risks.
  • The ETF's defensive nature during economic downturns attracts risk-averse investors.

What Does IYH Do?

The iShares U.S. Healthcare ETF (IYH) was launched to provide investors with a means to gain exposure to the performance of U.S. companies within the healthcare sector. It is managed by BlackRock, one of the largest asset management firms globally, which has a strong reputation for its ETFs. The fund aims to replicate the investment performance of an index that includes a diverse range of healthcare-related stocks, including those involved in pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. As of now, the ETF has a market capitalization of approximately $3.15 billion, reflecting its substantial presence in the financial markets. The ETF does not pay dividends, focusing instead on capital appreciation, which aligns with the growth potential of the healthcare sector. IYH's defensive nature during economic downturns is a potential strength, as healthcare tends to remain resilient in challenging economic climates. The ETF's holdings are diversified across various sub-sectors, which helps mitigate risks associated with individual companies. As healthcare continues to evolve with advancements in technology and increasing demand for healthcare services, IYH positions itself to benefit from these trends, making it an integral part of many investors' portfolios looking to tap into the growth of the healthcare industry.

What Products and Services Does IYH Offer?

  • iShares U.S. Healthcare ETF (IYH) provides investors with exposure to U.S. healthcare equities.
  • The ETF mirrors the performance of a benchmark index comprised of healthcare companies.
  • IYH includes stocks from various sub-sectors such as pharmaceuticals, biotechnology, and healthcare services.
  • The fund is managed by BlackRock, a leading global asset management firm.
  • IYH focuses on capital appreciation rather than income generation, as it does not pay dividends.
  • The ETF aims to offer diversified access to the healthcare sector, minimizing individual stock risk.

How Does IYH Make Money?

  • IYH generates revenue through management fees charged to investors.
  • The ETF's performance is tied to the underlying healthcare equities it holds.
  • IYH aims for capital appreciation by tracking the performance of a healthcare index.
  • The fund's diversified approach helps mitigate risks associated with individual stock performance.

What Industry Does IYH Operate In?

The asset management industry, particularly in the context of ETFs, has seen substantial growth, with healthcare ETFs gaining traction due to the sector's resilience and growth potential. The global healthcare market is projected to reach $11.9 trillion by 2027, driven by factors such as technological advancements, an aging population, and increasing healthcare spending. The competitive landscape includes various ETFs, with IYH distinguishing itself through its focused investment strategy on U.S. healthcare equities. This positioning allows IYH to capture the growth opportunities within a sector that is increasingly vital to the economy and society.

Who Are IYH's Key Customers?

  • Institutional investors seeking exposure to the healthcare sector.
  • Retail investors looking for diversified investment options in healthcare.
  • Financial advisors and wealth managers incorporating healthcare ETFs into client portfolios.
Model self-rating on this text: 65% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is an etf, not an operating company

MoonshotScore History

Recorded daily since 2026-08-23 · 41 snapshots

2026-08-23 46
2026-08-31 46
2026-09-08 46
2026-09-16 46
2026-09-24 46
2026-10-04 46

What changed?

The score has stayed at 46.

Over the same 30 days the stock moved -2.8%.

F-Score 3/9

Financial Health

iShares U.S. Healthcare ETF's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 40.92 places it in the safe zone, indicating low near-term bankruptcy risk.

IYH Financials

Bull Case vs Bear Case

Bull Case

  • Strong market capitalization of $3.15 billion indicates investor confidence.
  • Diversified exposure to various healthcare sectors mitigates risks.
  • Managed by BlackRock, ensuring robust management and operational expertise.

Bear Case

  • No dividend yield may deter income-focused investors.
  • Exposure to regulatory changes that could impact healthcare profitability.
  • Market volatility can affect ETF performance despite its defensive nature.
  • Ongoing regulatory scrutiny and potential policy changes affecting the healthcare sector.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

IYH Latest News

IYH Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for IYH.

Price Targets

Wall Street price target analysis for IYH.

IYH MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for IYH; grades run from A+ (80-100) to F (below 30).

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis